Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Mathieu Simon
Age : 65
Public asset : 362,664 USD
Country of residence : Unknown
Linked companies : Idorsia Ltd - Affimed N.V. - Lysogene S.A. - Asarina Pharma AB (publ)

Biography of Mathieu Simon 
Dr. Mathieu Simon is a Chairman at Epsilen Bio SRL, a Chairman at Idorsia Ltd., an Independent Director at Asarina Pharma AB, an Independent Director at Vaximm AG, a Chairman at Idorsia Pharmaceuticals Ltd., a Chief Executive Officer at Cellectis Therapeutics and an Independent Director at LNC Therapeutics SA. He is on the Board of Directors at Lysogene SA, Asarina Pharma AB, Affimed NV, Affimed GmbH, Vaximm AG, Messier Maris & Associés SCA and LNC Therapeutics SA. Dr. Simon was previously employed as an EVP, Chief Operating & Medical Officer by Cellectis SA, a Vice President-Marketing & Medical Affairs by Wyeth Pharmaceuticals LLC, a Group VP-Marketing & Clinical Affairs by Wyeth-Ayerst International, Inc., a Senior Vice President-Global Operations by Pierre Fabre Médicament SAS, a Managing Director & Head-Global Pharma by Pierre Fabre SA, and a Chairman & Chief Executive Officer by Takara Bio Europe AB. He also served on the board at Alliance for Regenerative Medicine, Ectycell SASU and Farmindustria.


Current positions of Mathieu Simon 
Holdings of Mathieu Simon 
Mathieu Simon : Personal Network 
Most Read News 
11/23ELON MUSK : Tesla's Musk exercises more options, sells shares worth $1.05 billion
RE
12/05MUKESH AMBANI : Indian salesmen threaten supply disruptions in protest against Reliance
RE
11/30JACK DORSEY : Jack Dorsey chases crypto, fintech dream post Twitter
RE
11/24JAMIE DIMON : Jamie Dimon jokes that JPMorgan will outlast China's Communist Party
RE
12/01JACK DORSEY : Dorsey-led Square rebrands to Block in nod to blockchain
RE
12/03CATHIE WOOD : Cathie Wood's ARK Innovation fund hits 13-month low in tech selloff
RE
11/26ELON MUSK : Tesla decides against state aid for German battery plant as Musk opposes subsidies
RE
12/02ELON MUSK : Musk exercises more options, sells Tesla shares worth $1.01 billion
RE
11/23ERIK NORDSTROM : Nordstrom warns of supply shortages as holiday season approaches, shares plunge
RE
12/02TILMAN FERTITTA : FAST Acquisition refuses to terminate SPAC merger with Fertitta Entertainment
RE
More news


© 2021 People and Ownership :   
Mathieu Simon : Connections 


Latest news about Mathieu Simon 
05/12PRESS RELEASE : Idorsia holds its Annual General Meeting of Shareholders
DJ
04/01PRESS RELEASE : Idorsia issues Notice of the 2021 Annual General Meeting of Shareholders
DJ
02/04PRESS RELEASE : Idorsia announces financial -3-
DJ
2019Lysogene S.A. Announces Board Changes
CI
2018Affimed N.V. Appoints Mathieu Simon as a Supervisory Director
CI
2018Cellectis Announces Executive Changes
CI
2017Cellectis S.A. Appoints Mathieu Simon as Interim Chief Medical Officer
CI
More news